The unfinished story of hydroxychloroquine in COVID-19: the right anti-inflammatory dose at the right moment?

Title
The unfinished story of hydroxychloroquine in COVID-19: the right anti-inflammatory dose at the right moment?
Authors
Keywords
hydroxychloroquine, COVID-19, inflammation, Interleukin-6, Tumor, Necrosis Factor-alpha, mortality, SARS-CoV-2
Journal
Publisher
Elsevier BV
Online
2020-10-17
DOI
10.1016/j.ijid.2020.10.032

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started